MANE acquires ChemoSensoryx Biosciences to strengthen receptor-based sensory science, accelerating innovation in flavors, fragrances, odor control, and taste modulation.
MANE has announced the acquisition of ChemoSensoryx Biosciences, a Belgium-based biotechnology firm widely recognized for its advanced scientific work in decoding the molecular foundations of chemosensory perception. This strategic move represents a significant step in MANE’s long-term vision to strengthen its research-driven approach and accelerate innovation across its global flavour and fragrance portfolio.
ChemoSensoryx Biosciences has built a strong reputation for its deep expertise in understanding how the human body perceives smells, tastes, and sensations. Its work focuses on the complex biological pathways governed by olfactory, gustatory, and trigeminal receptors—key elements that influence how consumers experience aromas, flavours, freshness, cooling effects, and pungency. By bringing this highly specialized scientific capability into the MANE group, the company aims to significantly expand its understanding of sensory perception at a molecular level.
The acquisition is expected to unlock new opportunities for MANE to design flavour and fragrance solutions with greater precision and predictability. By integrating ChemoSensoryx’s receptor-based screening and computational modeling platform with MANE’s extensive formulation expertise, the group plans to accelerate the development of next-generation sensory solutions. This combined approach allows researchers to better anticipate how specific molecules interact with human receptors, enabling the creation of more targeted, effective, and differentiated products for customers across food, beverage, personal care, and home care markets.
One of the key advantages of ChemoSensoryx’s technology lies in its ability to screen and model receptor responses with high accuracy. This capability strengthens MANE’s innovation pipeline in several strategic areas, including advanced odor control technologies such as FRESHPLEX, POWERBLOOM, and POWERLAST. These solutions are designed to manage malodors more efficiently and deliver longer-lasting freshness, responding to increasing consumer demand for superior performance in hygiene and household products.
Beyond odor control, the acquisition also enhances MANE’s research into taste modulation. ChemoSensoryx’s scientific insights support deeper exploration of taste dimensions such as sweetness, bitterness, umami, and kokumi. This is particularly valuable as food and beverage manufacturers seek to reformulate products by reducing sugar or salt while maintaining desirable taste profiles. Improved receptor-level understanding allows MANE to help customers meet regulatory requirements and evolving health-conscious consumer preferences without compromising sensory appeal.
In addition, the combined capabilities will support the design of highly targeted fragrance profiles and novel sensory effects. Research into cooling, warming, and pungent sensations—mediated through both olfactory and trigeminal receptors—opens the door to creating distinctive sensory signatures that stand out in competitive markets. These innovations are expected to play a key role in premium fragrances, oral care, and personal care applications where sensory differentiation is critical.
Overall, the acquisition of ChemoSensoryx Biosciences reinforces MANE’s commitment to science-led innovation and its ambition to remain at the forefront of the global flavour and fragrance industry. By investing in cutting-edge biotechnology and deep sensory science, MANE aims to deliver ever-evolving expertise and create successful, long-lasting products that resonate with consumers worldwide. This move underscores the company’s belief that a deeper understanding of human perception is essential to shaping the future of flavours and fragrances.
